OGN vs. GSK
Compare and contrast key facts about Organon & Co. (OGN) and GlaxoSmithKline plc (GSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OGN or GSK.
Correlation
The correlation between OGN and GSK is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
OGN vs. GSK - Performance Comparison
Key characteristics
OGN:
0.44
GSK:
-0.18
OGN:
0.96
GSK:
-0.10
OGN:
1.11
GSK:
0.99
OGN:
0.28
GSK:
-0.15
OGN:
1.21
GSK:
-0.34
OGN:
14.40%
GSK:
11.63%
OGN:
39.42%
GSK:
22.00%
OGN:
-69.56%
GSK:
-55.21%
OGN:
-57.15%
GSK:
-24.87%
Fundamentals
OGN:
$3.80B
GSK:
$69.84B
OGN:
$5.05
GSK:
$1.54
OGN:
2.92
GSK:
22.23
OGN:
$6.41B
GSK:
$31.27B
OGN:
$3.73B
GSK:
$22.46B
OGN:
$1.69B
GSK:
$7.73B
Returns By Period
In the year-to-date period, OGN achieves a 6.90% return, which is significantly higher than GSK's -5.50% return.
OGN
6.90%
-3.91%
-26.41%
14.02%
N/A
N/A
GSK
-5.50%
0.00%
-16.00%
-4.05%
-2.62%
2.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
OGN vs. GSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
OGN vs. GSK - Dividend Comparison
OGN's dividend yield for the trailing twelve months is around 7.72%, more than GSK's 4.62% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OGN Organon & Co. | 7.72% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GSK GlaxoSmithKline plc | 4.62% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% | 4.43% |
Drawdowns
OGN vs. GSK - Drawdown Comparison
The maximum OGN drawdown since its inception was -69.56%, which is greater than GSK's maximum drawdown of -55.21%. Use the drawdown chart below to compare losses from any high point for OGN and GSK. For additional features, visit the drawdowns tool.
Volatility
OGN vs. GSK - Volatility Comparison
Organon & Co. (OGN) has a higher volatility of 11.38% compared to GlaxoSmithKline plc (GSK) at 6.76%. This indicates that OGN's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
OGN vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Organon & Co. and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities